BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 20045054)

  • 1. Modulation of astrocyte glutamate transporters decreases seizures in a mouse model of Tuberous Sclerosis Complex.
    Zeng LH; Bero AW; Zhang B; Holtzman DM; Wong M
    Neurobiol Dis; 2010 Mar; 37(3):764-71. PubMed ID: 20045054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microglial activation during epileptogenesis in a mouse model of tuberous sclerosis complex.
    Zhang B; Zou J; Han L; Rensing N; Wong M
    Epilepsia; 2016 Aug; 57(8):1317-25. PubMed ID: 27263494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epileptogenesis and reduced inward rectifier potassium current in tuberous sclerosis complex-1-deficient astrocytes.
    Jansen LA; Uhlmann EJ; Crino PB; Gutmann DH; Wong M
    Epilepsia; 2005 Dec; 46(12):1871-80. PubMed ID: 16393152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of tuberous sclerosis complex.
    Zeng LH; Rensing NR; Zhang B; Gutmann DH; Gambello MJ; Wong M
    Hum Mol Genet; 2011 Feb; 20(3):445-54. PubMed ID: 21062901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal glutamate homeostasis and impaired synaptic plasticity and learning in a mouse model of tuberous sclerosis complex.
    Zeng LH; Ouyang Y; Gazit V; Cirrito JR; Jansen LA; Ess KC; Yamada KA; Wozniak DF; Holtzman DM; Gutmann DH; Wong M
    Neurobiol Dis; 2007 Nov; 28(2):184-96. PubMed ID: 17714952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex.
    Zeng LH; Xu L; Gutmann DH; Wong M
    Ann Neurol; 2008 Apr; 63(4):444-53. PubMed ID: 18389497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired glial glutamate transport in a mouse tuberous sclerosis epilepsy model.
    Wong M; Ess KC; Uhlmann EJ; Jansen LA; Li W; Crino PB; Mennerick S; Yamada KA; Gutmann DH
    Ann Neurol; 2003 Aug; 54(2):251-6. PubMed ID: 12891680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The natural history and treatment of epilepsy in a murine model of tuberous sclerosis.
    Erbayat-Altay E; Zeng LH; Xu L; Gutmann DH; Wong M
    Epilepsia; 2007 Aug; 48(8):1470-6. PubMed ID: 17484760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired astrocytic gap junction coupling and potassium buffering in a mouse model of tuberous sclerosis complex.
    Xu L; Zeng LH; Wong M
    Neurobiol Dis; 2009 May; 34(2):291-9. PubMed ID: 19385061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The specificity and role of microglia in epileptogenesis in mouse models of tuberous sclerosis complex.
    Zhang B; Zou J; Han L; Beeler B; Friedman JL; Griffin E; Piao YS; Rensing NR; Wong M
    Epilepsia; 2018 Sep; 59(9):1796-1806. PubMed ID: 30079598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral vascular and blood brain-barrier abnormalities in a mouse model of epilepsy and tuberous sclerosis complex.
    Guo D; Zhang B; Han L; Rensing NR; Wong M
    Epilepsia; 2024 Feb; 65(2):483-496. PubMed ID: 38049961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postnatal reduction of tuberous sclerosis complex 1 expression in astrocytes and neurons causes seizures in an age-dependent manner.
    Zou J; Zhang B; Gutmann DH; Wong M
    Epilepsia; 2017 Dec; 58(12):2053-2063. PubMed ID: 29023667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory mechanisms contribute to the neurological manifestations of tuberous sclerosis complex.
    Zhang B; Zou J; Rensing NR; Yang M; Wong M
    Neurobiol Dis; 2015 Aug; 80():70-9. PubMed ID: 26003087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of glial fibrillary acidic protein results in decreased glutamate transport and inhibition of PKA-induced EAAT2 cell surface trafficking.
    Hughes EG; Maguire JL; McMinn MT; Scholz RE; Sutherland ML
    Brain Res Mol Brain Res; 2004 May; 124(2):114-23. PubMed ID: 15135219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A circuitry and biochemical basis for tuberous sclerosis symptoms: from epilepsy to neurocognitive deficits.
    Feliciano DM; Lin TV; Hartman NW; Bartley CM; Kubera C; Hsieh L; Lafourcade C; O'Keefe RA; Bordey A
    Int J Dev Neurosci; 2013 Nov; 31(7):667-78. PubMed ID: 23485365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberous sclerosis and epilepsy: role of astrocytes.
    Wong M; Crino PB
    Glia; 2012 Aug; 60(8):1244-50. PubMed ID: 22438024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early developmental electroencephalography abnormalities, neonatal seizures, and induced spasms in a mouse model of tuberous sclerosis complex.
    Rensing N; Johnson KJ; Foutz TJ; Friedman JL; Galindo R; Wong M
    Epilepsia; 2020 May; 61(5):879-891. PubMed ID: 32274803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of astrocyte glutamate transporter-1 (GLT1) and aquaporin-4 (AQP4) expression in a model of epilepsy.
    Hubbard JA; Szu JI; Yonan JM; Binder DK
    Exp Neurol; 2016 Sep; 283(Pt A):85-96. PubMed ID: 27155358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression profiling in tuberous sclerosis complex (TSC) knockout mouse astrocytes to characterize human TSC brain pathology.
    Ess KC; Uhlmann EJ; Li W; Li H; Declue JE; Crino PB; Gutmann DH
    Glia; 2004 Apr; 46(1):28-40. PubMed ID: 14999811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of tuberous sclerosis complex 1 (Tsc1) expression results in increased Rheb/S6K pathway signaling important for astrocyte cell size regulation.
    Uhlmann EJ; Li W; Scheidenhelm DK; Gau CL; Tamanoi F; Gutmann DH
    Glia; 2004 Aug; 47(2):180-8. PubMed ID: 15185396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.